% With symptoms, BHETSE study (n = 57) | % With symptoms, All Ireland Bar Study11 (n = 138) | % With symptoms, California study (n = 53)† | ||||
Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | |
Respiratory symptoms | ||||||
Median (IQR) number of symptoms | 1 (0–2) | 0 (0–2) | 1 (0–2) | 0 (0–2)** | NA | NA |
Any symptom | 54 | 39 | 65 | 49** | 74 | 32** |
Wheezing/whistling | 25 | 21 | 21 | 20 | 32 | 15** |
Shortness of breath | 23 | 20 | 16 | 16 | 19 | 8* |
Cough, morning | 23 | 12* | 21 | 15 | 53 | 23** |
Cough, rest of day or night | 35 | 23 | 38 | 25** | 49 | 11** |
Phlegm production | 32 | 14** | 43 | 29** | 53 | 11** |
Sensory symptoms | ||||||
Median number of symptoms | 2 (0–2) | 1 (0–2)* | 1 (0–2) | 0 (0–1)** | NA | NA |
Any symptom | 74 | 60 | 67 | 45** | 77 | 19** |
Eyes, red or irritated | 44 | 18** | 41 | 14** | 42 | 6** |
Nose, runny or sneezing | 54 | 51 | 44 | 35 | 60 | 15** |
Throat, sore or scratchy | 47 | 37 | 33 | 19** | 25 | 13* |
*p<0.1, **p<0.05, for follow-up versus baseline.
†The study of California bar workers10 includes data from smokers. Follow-up was within 8 weeks of baseline compared to 1 year for the BHETSE study and the All Ireland Bar Study.
IQR, interquartile range.